In sensitivity analyses, after excluding CKM patients who died within the first two-year follow-up and those with a history of cancer, and the association between each OBS and mortality outcome remained significant (Supplementary Table S13 and Supplementary Table S14). This evidence concerns the gene CKM and cancer.